K5
K5 has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 17, 2025: “A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties”.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Consiglio Nazionale Delle Ricerche and 3 more
- Animals1
What did studies of K5 find?
4Studies of K5 measured 4 outcomes, among them HSP90AA1, lifespan and senescence markers.
HSP90AA1
downin human cells1
1 study
HSP90AA1
downin human cells1
K5 inhibits HSP90AA1 in human cells.
“the xanthinic nature of K5 implicates a multimodal action, now including the inhibition of HSP90α”
Cells
A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties
Aging cell
Lifespan
upin flies1
1 study
Lifespan
upin flies1
K5 extends lifespan in flies.
“It was also effective in vivo, extending lifespan in Drosophila”
Model organisms
A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties
Aging cell
Senescence markers
downin mice1
1 study
Senescence markers
downin mice1
K5 decreases senescence markers in mice.
“reducing senescence markers in geriatric mice”
Animals
A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties
Aging cell
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
K5 decreases cellular senescence in human cells across cellular senescence models (senolytic index SI > 1320 for IMR90 cells and SI > 770 for WI38 cells).
“K5 demonstrated senolytic activity across various cellular senescence models, including human fibroblasts, mesenchymal stem cells, and breast cancer cells.”
Cellsacross cellular senescence models
A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties
Aging cell